Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


04.10.2021

1 Ann Intern Med
4 BMJ
10 J Infect Dis
3 JAMA
1 Lancet
4 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
3 Nat Med
2 Pediatr Infect Dis J
2 PLoS Med
2 PLoS One
4 Science
11 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. CURTIS JR, Cofield SS, Bridges SL Jr, Bassler J, et al
    The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial.
    Ann Intern Med. 2021 Sep 28. doi: 10.7326/M20-6928.
    PubMed         Abstract available


    BMJ

  2. MAJEED A, Hodes S, Marks S
    Consent for covid-19 vaccination in children.
    BMJ. 2021;374:n2356.
    PubMed        

  3. MAHASE E
    Covid-19: Fully vaccinated patients no longer need to test or isolate before elective procedures, hospitals are told.
    BMJ. 2021;374:n2383.
    PubMed        

  4. DYER O
    Covid-19: New York's health workers agree to vaccinate as mandate bites.
    BMJ. 2021;374:n2390.
    PubMed        

  5. MENDIS S
    Regional vaccine production is key to ensuring equity.
    BMJ. 2021;374:n2354.
    PubMed        


    J Infect Dis

  6. HARBECKE R, Cohen JI, Oxman MN
    Herpes Zoster Vaccines.
    J Infect Dis. 2021;224.
    PubMed         Abstract available

  7. GILSDORF JR
    Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease.
    J Infect Dis. 2021;224.
    PubMed         Abstract available

  8. FERREIRA IATM, Kemp SA, Datir R, Saito A, et al
    SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
    J Infect Dis. 2021;224:989-994.
    PubMed         Abstract available

  9. HU SY, Tsang SH, Chen F, Pan QJ, et al
    Association between Common Vaginal Infections and Cervical Non-HPV16/18 Infection in HPV-Vaccinated Women.
    J Infect Dis. 2020 Jul 2. pii: 5866538. doi: 10.1093.
    PubMed         Abstract available

  10. RODGERS GL, Whitney CG, Klugman KP
    Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe.
    J Infect Dis. 2021;224.
    PubMed         Abstract available

  11. PATTYN J, Hendrickx G, Vorsters A, Van Damme P, et al
    Hepatitis B Vaccines.
    J Infect Dis. 2021;224.
    PubMed         Abstract available

  12. BECKER T, Elbahesh H, Reperant LA, Rimmelzwaan GF, et al
    Influenza Vaccines: Successes and Continuing Challenges.
    J Infect Dis. 2021;224.
    PubMed         Abstract available

  13. GERSHON AA, Gershon MD, Shapiro ED
    Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster.
    J Infect Dis. 2021;224.
    PubMed         Abstract available

  14. MARKOWITZ LE, Schiller JT
    Human Papillomavirus Vaccines.
    J Infect Dis. 2021;224.
    PubMed         Abstract available

  15. GLASS RI, Tate JE, Jiang B, Parashar U, et al
    The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease.
    J Infect Dis. 2021;224.
    PubMed         Abstract available


    JAMA

  16. DEL RIO C, Malani PN, Omer SB
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
    PubMed        

  17. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
    PubMed        

  18. RUBIN R
    COVID-19 Vaccine Nasal Spray.
    JAMA. 2021;326:1138.
    PubMed        


    Lancet

  19. FLAXMAN A, Marchevsky NG, Jenkin D, Aboagye J, et al
    Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01699.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  20. HAUSE AM, Baggs J, Gee J, Marquez P, et al
    Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1379-1384.
    PubMed         Abstract available

  21. MBAEYI C, Baig S, Khan Z, Young H, et al
    Progress Toward Poliomyelitis Eradication - Pakistan, January 2020-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1359-1364.
    PubMed         Abstract available

  22. RYERSON AB, Rice CE, Hung MC, Patel SA, et al
    Disparities in COVID-19 Vaccination Status, Intent, and Perceived Access for Noninstitutionalized Adults, by Disability Status - National Immunization Survey Adult COVID Module, United States, May 30-June 26, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1365-1371.
    PubMed         Abstract available

  23. HAGAN LM, McCormick DW, Lee C, Sleweon S, et al
    Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1349-1354.
    PubMed         Abstract available


    N Engl J Med

  24. STUART LM
    In Gratitude for mRNA Vaccines.
    N Engl J Med. 2021 Sep 24. doi: 10.1056/NEJMcibr2111445.
    PubMed        

  25. JUNG J, Sung H, Kim SH
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2021;385.
    PubMed        

  26. AMIT S, Gonen T, Regev-Yochay G
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.
    N Engl J Med. 2021;385.
    PubMed        

  27. FALSEY AR, Sobieszczyk ME, Hirsch I, Sproule S, et al
    Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
    N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2105290.
    PubMed         Abstract available


    Nat Med

  28. O'LEARY K
    Low-dose mRNA vaccination measures up.
    Nat Med. 2021 Sep 30. pii: 10.1038/d41591-021-00060.
    PubMed        

  29. SHROFF RT, Chalasani P, Wei R, Pennington D, et al
    Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.
    Nat Med. 2021 Sep 30. pii: 10.1038/s41591-021-01542.
    PubMed         Abstract available

  30. CHOOKAJORN T, Kochakarn T, Wilasang C, Kotanan N, et al
    Southeast Asia is an emerging hotspot for COVID-19.
    Nat Med. 2021;27:1495-1496.
    PubMed        


    Pediatr Infect Dis J

  31. KAWAMURA Y, Suzuki D, Kono T, Miura H, et al
    A Case of Aseptic Meningitis Without Skin Rash Caused by Oka Varicella Vaccine.
    Pediatr Infect Dis J. 2021 Aug 24. pii: 00006454-900000000-95700.
    PubMed         Abstract available

  32. WATSON G, Dodd C, Munoz FM, Eckert LO, et al
    Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries.
    Pediatr Infect Dis J. 2021 Sep 28. pii: 00006454-900000000-95658.
    PubMed         Abstract available


    PLoS Med

  33. NAGATA JM, Epstein A, Ganson KT, Benmarhnia T, et al
    Drought and child vaccination coverage in 22 countries in sub-Saharan Africa: A retrospective analysis of national survey data from 2011 to 2019.
    PLoS Med. 2021;18:e1003678.
    PubMed         Abstract available

  34. FORMICA N, Mallory R, Albert G, Robinson M, et al
    Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
    PLoS Med. 2021;18:e1003769.
    PubMed         Abstract available


    PLoS One

  35. KIM MH, Son NH, Park YS, Lee JH, et al
    Effect of a hospital-wide campaign on COVID-19 vaccination uptake among healthcare workers in the context of raised concerns for life-threatening side effects.
    PLoS One. 2021;16:e0258236.
    PubMed         Abstract available

  36. ROBERTSON CT, Bentele K, Meyerson B, Wood ASA, et al
    Effects of political versus expert messaging on vaccination intentions of Trump voters.
    PLoS One. 2021;16:e0257988.
    PubMed         Abstract available


    Science

  37. COHEN J
    New Chinese vaccine could bolster global arsenal.
    Science. 2021;374:12-13.
    PubMed         Abstract available

  38. PINTO D, Sauer MM, Czudnochowski N, Low JS, et al
    Broad betacoronavirus neutralization by a stem helix-specific human antibody.
    Science. 2021 Aug 3. pii: science.abj3321. doi: 10.1126/science.abj3321.
    PubMed         Abstract available

  39. WADMAN M
    Israel's high case plateau may offer worrisome portent.
    Science. 2021;373:1428-1429.
    PubMed         Abstract available

  40. WADMAN M
    SARS-CoV-2 infection confers greater immunity than shots.
    Science. 2021;373:1067-1068.
    PubMed         Abstract available


    Vaccine

  41. MOON JE, Greenleaf ME, Regules JA, Debois M, et al
    A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge.
    Vaccine. 2021 Sep 27. pii: S0264-410X(21)01203.
    PubMed         Abstract available

  42. GIESE H, Neth H, Gaissmaier W
    Determinants of information diffusion in online communication on vaccination: The benefits of visual displays.
    Vaccine. 2021 Sep 21. pii: S0264-410X(21)01195.
    PubMed         Abstract available

  43. SULIMAN DM, Nawaz FA, Mohanan P, Modber MAKA, et al
    UAE efforts in promoting COVID-19 vaccination and building vaccine confidence.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01194.
    PubMed         Abstract available

  44. LIU CH, Huang WT, Chie WC, Arnold Chan K, et al
    Safety surveillance of varicella vaccine using tree-temporal scan analysis.
    Vaccine. 2021 Sep 21. pii: S0264-410X(21)01226.
    PubMed         Abstract available

  45. MANSUY JM, Sagna AS, Laurent M, Izopet J, et al
    COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination?
    Vaccine. 2021 Sep 17. pii: S0264-410X(21)01227.
    PubMed        

  46. MELGAARD A, Krogsgaard LW, Randrup T, Plana-Ripoll O, et al
    Pre-vaccination vulnerability and suspected adverse events following HPV vaccination. A case-control study nested in the Danish national birth cohort.
    Vaccine. 2021 Sep 21. pii: S0264-410X(21)01232.
    PubMed         Abstract available

  47. CHOWDHURY F, Akter A, Rahman Bhuiyan T, Tauheed I, et al
    A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh.
    Vaccine. 2021 Sep 21. pii: S0264-410X(21)01222.
    PubMed         Abstract available

  48. YAMAZAKI Y, Ikeda M, Imada T, Furuno K, et al
    A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased ris
    Vaccine. 2021 Sep 23. pii: S0264-410X(21)01168.
    PubMed         Abstract available

  49. AKSNES BN, Walldorf JA, Nkwenkeu SF, Zoma RL, et al
    Vaccination information, motivations, and barriers in the context of meningococcal serogroup A conjugate vaccine introduction: A qualitative assessment among caregivers in Burkina Faso, 2018.
    Vaccine. 2021 Sep 24. pii: S0264-410X(21)01229.
    PubMed         Abstract available

  50. CASEY RM, Adrien N, Badiane O, Diallo A, et al
    National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
    Vaccine. 2021 Sep 27. pii: S0264-410X(21)01075.
    PubMed         Abstract available

  51. ZENG W, Cui Y, Jarawan E, Avila C, et al
    Optimizing immunization schedules in endemic cholera regions: cost-effectiveness assessment of vaccination strategies for cholera control in Bangladesh.
    Vaccine. 2021 Sep 24. pii: S0264-410X(21)01235.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: